Cargando…
Evaluating and Improving Neonatal Gentamicin Pharmacokinetic Models Using Aggregated Routine Clinical Care Data
Model-informed precision dosing (MIPD) can aid dose decision-making for drugs such as gentamicin that have high inter-individual variability, a narrow therapeutic window, and a high risk of exposure-related adverse events. However, MIPD in neonates is challenging due to their dynamic development and...
Autores principales: | Tong, Dominic M. H., Hughes, Jasmine H., Keizer, Ron J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609639/ https://www.ncbi.nlm.nih.gov/pubmed/36297524 http://dx.doi.org/10.3390/pharmaceutics14102089 |
Ejemplares similares
-
Evaluation of Neonatal and Paediatric Vancomycin Pharmacokinetic Models and the Impact of Maturation and Serum Creatinine Covariates in a Large Multicentre Data Set
por: Hughes, Jasmine H., et al.
Publicado: (2022) -
Physiologically-based pharmacokinetic modelling and dosing evaluation of gentamicin in neonates using PhysPK
por: Zazo, Hinojal, et al.
Publicado: (2022) -
A hybrid machine learning/pharmacokinetic approach outperforms maximum a posteriori Bayesian estimation by selectively flattening model priors
por: Hughes, Jasmine H., et al.
Publicado: (2021) -
Evaluation of Dosing Guidelines for Gentamicin in Neonates and Children
por: Hollander, Esther M., et al.
Publicado: (2023) -
Pharmacokinetic approach for optimizing gentamicin use in neonates during the first week of life
por: Ali, Ahmed S., et al.
Publicado: (2012)